More from Investing
Freeport-McMoRan is always going to be my first call on the health of copper.
What we are hearing is that the Fed is data-dependent and is aware of the potential problems caused by the trade dispute and other issues.
Alexion Pharmaceuticals is a solid company that is the subject of acquisition rumors and Amicus Therapeutics has a key drug off to a strong start.
Resistance levels were tested again but failed to breach to the upside.
Shares of several retailers rode the coattails of Nordstrom and Dick's Sporting Goods on their favorable earnings releases Thursday, but Friday offers a mixed bag.